Plants
Global Plants
Maximizing our accumulated knowhow, we have acquired or built plants in strategic geographical locations that better enable us to address the local markets' needs.
IndonesiaSurabaya Plant
Surabaya- Feature
- Dedicated for Biological products
(EPO, EGF, Somatropin) - Independent production lines preventing cross-contamination
- HALAL certified process management from drug substance to finished products
- Capacity: Prefilled Syringe (4M)
- Area
- 2,484 m2 (26,737 ft2)
- Manufacturing Products
- Biopharmaceutical Products
(EPO, EGF, hGH, BMP)
ChinaLiaoning Plant
Liaoning- Feature
- Closed system throughout the production process
- BIN System based transfer and handling
- Unmanned ingredient transfer using line and pump
- Capacity: Oral Liquid (200M pouch, 30M bottle)
- Area
- 9,586 m2 (103,182 ft2)
- Manufacturing Products
- Liquid for oral administration
ChinaSichuan Plant
Sichuan- Feature
- Top gall bladder-related production technology
- UDCA intermediate production
- API & CDCA (Chenodeoxycholic acid)
- Area
- 10,000 m2 (107,639 ft2)
- Manufacturing Products
- Chenodeoxycholic acid, crude Cholic acid
Total Capacity per Year
| Type | Quantity |
|---|---|
| Tablet | 6.7 Billion |
| Capsule | 205 Million |
| Vial | 70 Million |
| Bottle | 102 Million |
| Pouch | 130 Million |
| Syringe | 5.6 Million |
| Bag | 0.5 Million |
| Ampoule | 0.1 Billion |
| Kit | 7 Million |